AstraZeneca and Microsoft to develop ‘drag and drop’ cancer simulation

AstraZeneca has entered into a partnership with tech giant Microsoft to develop a new computerised modelling system which promises to enable scientists to streamline their work and conduct experiments at much higher volume and speed.
BioModel Analyzer, the new cloud-based system, comprises a ‘drag and drop’ interface and models millions of key signalling pathways in cancer cells and the two companies believe it will reduce the need for ‘wet’ lab experiments and speed the industry on the pathway to truly personalised medicine.
read more http://www.pharmafile.com/news/508560/astrazeneca-and-microsoft-develop-drag-and-drop-cancer-simulation